organophosphonates has been researched along with Glycogen Storage Disease Type II in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, I; Caillaud, C; Charbonné, HV; Da Silva, A; Daurat, M; El Cheikh, K; Garcia, M; Gary-Bobo, M; Godefroy, A; Maynadier, M; Morère, A; Sacconi, S; Schoser, B | 1 |
1 other study(ies) available for organophosphonates and Glycogen Storage Disease Type II
| Article | Year |
|---|---|
Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease.
Topics: Adult; Animals; Cells, Cultured; Disease Models, Animal; Glycogen Storage Disease Type II; Humans; Lysosomes; Mannose; Mice; Muscle, Skeletal; Myoblasts; Organophosphonates | 2019 |